Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Methods for treating or preventing pain and anxiety

a technology of pain and anxiety, applied in the field of pain and anxiety treatment or prevention, can solve the problems that none of the known benzanilide analogues are disclosed to open the potassium channel or to be of us

Inactive Publication Date: 2002-01-31
WICKENDEN ALAN DAVID +3
View PDF11 Cites 30 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Moreover, none of the known benzanilide analogues are disclosed to open potassium channels or to be of use in treating conditions involving the modulation of potassium channels.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Methods for treating or preventing pain and anxiety
  • Methods for treating or preventing pain and anxiety
  • Methods for treating or preventing pain and anxiety

Examples

Experimental program
Comparison scheme
Effect test

example 1

Expression of KCNQ2 and KCNQ3 mRNA in Human Dorsal Root Ganglion

[0140] Expression of KCNQ2 and KCNQ3 mRNA was detected by PCR amplification of human dorsal root ganglion (DRG) cDNA. cDNA was prepared by reverse transcription of total RNA from human DRG using standard procedures. A second mock reverse-transcription reaction was also performed, which was identical to the first, except for the omission of the reverse transcriptase. 35 cycles of amplification were performed on a single microliter of human DRG cDNA, using oligonucleotide primers designed to amplify either KCNQ2 or KCNQ3.

[0141] For KCNQ2, the oligonucleotides used for the amplification were: 5'-GGCTCGGTCCCCCACAGTCAG-3' (sense) and 5'-CTCCACGGCAGGTCCAAGTCTCA-3' (antisense).

[0142] For KCNQ3, the oligonucleotides were: 5'-GCCCACGGTCCTGCCTATCTT-3' (sense) and 5'-CATTGGTGTCCCCGCTGGTAA-3' (antisense).

[0143] PCR amplified DNA fragments were separated by agarose gel electrophoresis, visualized using ethidium bromide staining and ...

example 2

Expression of Recombinant KCNO2 / 3 Channel CHO Cells

[0144] A cloned KCNQ2 / 3 channel was expressed in chinese hamster ovary cells (CHO-K1 cells) according to standard methodology. CHO-K1 cells were transfected with human KCNQ2 / 3 nucleic acid using lipofectamine reagent according to the manufacturer's instructions. Cells stably expressing KCNQ2 / 3 were identified by their resistance to G418 (400 .mu.g / ml). CHO-K1 cells stably transfected with the KCNQ2 / 3 tandem construct were maintained in Ham's F-12 supplemented with 10% heat-inactivated fetal bovine serum and 400 .mu.g / ml G418 in an incubator at 37.degree. C. with a humidified atmosphere of 5% CO.sub.2.

[0145] For modulation of KCNQ channels, a benzanilide KCNQ channel opener was applied to the cells. The compound increased holding current at 40 mV (see FIG. 2) and hyperpolarized the membrane potential.

example 3

Expression of Endogenous KCNO2 / 3 Channel in DRGs

[0146] DRGs were isolated from 1 day old Sprague-Dawley rats. DRGs were dissociated using trypsin (0.25%) and protease type XXIII (2 mg / ml) and neurons were maintained in culture in 90% Eagles MEM (without L-glutamate), 10% FCS, 100 U / m; penicillin, 100 g / ml streptomycin, in an incubator at 37.degree. C. with a humidified atmosphere of 5% CO.sub.2.

[0147] As described above, a benzanilide KCNQ channel opener was applied to the cells. The opener increased holding current at -30 mV and hyperpolarized the membrane potential (see FIG. 3).

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
membrane potentialaaaaaaaaaa
temperatureaaaaaaaaaa
resting membrane potentialaaaaaaaaaa
Login to View More

Abstract

The present invention relates to a novel method of treating of pain or anxiety, using compounds that modulate KCNQ potassium channels and currents.

Description

CROSS-REFERENCES TO RELATED APPLICATIONS[0001] This application claims priority to U.S. Ser. No. 09 / 631,747, filed Aug. 4, 2000; U.S. Ser. No. 60 / 147,221, filed Aug. 4, 1999; U.S. Ser. No. 60 / 158,712, filed Oct. 8, 1999; and U.S. Ser. No. 60 / 165,847, filed Nov. 16, 1999, herein each incorporated by reference in their entirety.[0002] This application is related to U.S. Ser. No. 09 / 632,576, filed Aug. 4, 2000, herein incorporated by reference in its entirety.STATEMENT AS TO RIGHTS TO INVENTIONS MADE UNDER FEDERALLY SPONSORED RESEARCH AND DEVELOPMENT[0003] Not applicable.[0004] Ion channels are cellular proteins that regulate the flow of ions, including calcium, potassium, sodium and chloride, into and out of cells. These channels are present in all human cells and affect such processes as nerve transmission, muscle contraction and cellular secretion. Among the ion channels, potassium channels are the most ubiquitous and diverse, being found in a variety of animal cells such as nervous...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(United States)
IPC IPC(8): C07D213/75A61K31/00A61K31/44A61K45/00A61P3/10A61P17/00A61P17/02A61P19/00A61P21/00A61P25/00A61P25/02A61P25/22A61P29/00A61P31/00A61P31/04A61P31/12A61P31/18A61P35/00A61P37/00C07D401/12C07D405/12C07D409/12C07D417/12
CPCA61K31/00A61K31/44C07D213/75C07D401/12C07D405/12C07D409/12C07D417/12A61P3/10A61P17/00A61P17/02A61P19/00A61P21/00A61P25/00A61P25/02A61P25/04A61P25/22A61P29/00A61P31/00A61P31/04A61P31/12A61P31/18A61P35/00A61P37/00A61P43/00
Inventor WICKENDEN, ALAN DAVIDRIGDON, GREGORY COOKSEYMCNAUGHTON-SMITH, GRANT ANDREWGROSS, MICHAEL FRANCIS
Owner WICKENDEN ALAN DAVID
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com